title: Vascular and blood pressure effects of folic acid in older patients with cardiovascular disease.
authors.forename: A A
authors.initials: AA
authors.lastname: Mangoni
authors.forename: E
authors.initials: E
authors.lastname: Ouldred
authors.forename: C G
authors.initials: CG
authors.lastname: Swif
authors.forename: S H
authors.initials: SH
authors.lastname: Jackson
authors.forename: R P
authors.initials: RP
authors.lastname: Draper
authors.forename: R A
authors.initials: RA
authors.lastname: Sherwood
authors.forename: M
authors.initials: M
authors.lastname: Lambert-Hammill
authors.forename: A S
authors.initials: AS
authors.lastname: Wierzbicki
mesh_terms: D001783:Blood Flow Velocity / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects*; D005492:Folic Acid / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D020138:Hyperhomocysteinemia / Q000097:blood / Q000150:complications* / Q000188:drug therapy* / Q000235:genetics; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D009203:Myocardial Infarction / Q000209:etiology* / Q000503:physiopathology; D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000235:genetics; D012044:Regression Analysis; D012307:Risk Factors; D012720:Severity of Illness Index; D020521:Stroke / Q000209:etiology* / Q000503:physiopathology
chemical_list: D005492:Folic Acid; D000587:Oxidoreductases Acting on CH-NH Group Donors; D042965:Methylenetetrahydrofolate Reductase (NADPH2)